Science being propelled on several fronts by structuring grants
From left to right: Michel Cayouette, Jacques Drouin, Mathieu Ferron, David Hipfner, Marie Kmita, Rémi Rabasa-Lhoret and François Robert.
The Montreal Clinical Research Institute (IRCM) is proud to highlight the excellent results of its researchers in the latest competition of the Canadian Institutes of Health Research (CIHR)'s Spring Project Grants competition. While the national success average is 15% in this competition, the IRCM reached an enviable rate of 32% for the applications submitted.
Reflecting the diversity and richness of the work carried out in IRCM’s laboratories, these research projects will thus unfold their full potential to pave the way towards therapeutic avenues for important diseases, as they examine various areas of human understanding of science.
“These invaluable grants will enable our teams to pursue work of hitherto unsuspected scope, and for this, we're very grateful,” enthused Dr. Jean-François Côté, President and Scientific Director of the IRCM, adding: ”Every therapy and every drug find their origins in fundamental research, and I'm convinced that these funds will make a major contribution to the advancement of knowledge that will lead to cures.’’
Selected projects
- Dr. Michel Cayouette receives $1,193,400 over 5 years for his project entitled: Regenerating the nervous system through glia reprogramming.
- Dr. Jacques Drouin receives $1,235,476 over 5 years for How do pioneer factors open chromatin?
- Dr. Mathieu Ferron receives $973,846 over 5 years for Role of the vitamin K reductase VKORC1L1 in NAFDL and hepatocellular carcinoma.
- Dr. Rémi Rabasa-Lhoret (with Dr. Jane Yardley) receives $416,924 over 3 years for Updating preventing and treatment guidelines for mild hypoglycemia in individuals with type 1 diabetes during the era of continuous glucose.
- Dr. François Robert receives $933,300 over 5 years for A multi-scale mechanism for the RNAPII CTD.
- Dr. David Hipfner, in collaboration with Sébastien Carréno (Institute for Research in Immunology and Cancer, Université de Montréal), receives $956,250 over 5 years for the project they are co-directing entitled: Long distance cell-cell communication by cytonemes.
Dr. Marie Kmita is awarded a one-year transitional grant of $100,000 for her project Hox pioneering activity in development and disease.
The IRCM congratulates all the researchers who submitted grant applications, and warmly thanks all those who reviewed their colleagues' funding applications as part of the internal review process. The Institute also extends its warmest thanks to the Canadian Institutes of Health Research.
